The Specific Carbohydrate Diet is a nutritional regimen used to treat a variety of chronic and auto-immune disorders including Crohn’s Disease, Ulcerative Colitis, Diverticulitis, Celiac Disease, Autism and Cystic Fibrosis.
Therapy that introduces normal ‘good’ human flora from a donor into a patient’s bowel to eradicate pathogenic ‘bad’ bacteria.
Up to 95% of Dr. Thomas Borody’s patients with Crohn’s disease have responded to treatment with a triple antibiotic regimen of rifabutin, clarythromycin, and clofazimine.
The first commercially available TNF antagonist. TNFα is one of the key cytokines that triggers and sustains the inflammation response.
A group of University of Iowa Health Care researchers has proposed that underexposure to intestinal helminths is a major environmental factor predisposing to IBD.
A British study has found that cannabis-based drugs could prove effective for treating inflammatory bowel disease (IBD).
